nicotine has been researched along with eticlopride in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Besheer, J; Bevins, RA; Pickett, KS | 1 |
| Gasparini, F; Harrison, AA; Markou, A | 1 |
| Bevins, RA; Palmatier, MI | 1 |
| Bardo, MT; Brown, RW; Dwoskin, LP; Green, TA; Phillips, SB | 1 |
| Lajtha, A; Rossi, S; Sershen, H; Shearman, E; Singer, S | 1 |
| Alburges, ME; Hanson, GR; Hoonakker, AJ | 1 |
| Dani, JA; Liang, Y; Siapas, AG; Zhang, L; Zhang, T; Zhou, FM | 1 |
| Brown, RW; Cope, ZA; Lehmann, J; Sheppard, B | 1 |
| Booth, S; Caggiula, AR; Gharib, M; Jernigen, C; Liu, X; Sved, AF | 1 |
| Fletcher, PJ; Guy, EG | 1 |
| Brianna Sheppard, A; Brown, RW; Kellicut, MR; Palmatier, MI; Robinson, DL | 1 |
| Balachandran, RC; Eubig, PA; Hatcher, KM; Mahoney, MM; Molina, LM; Sieg, ML; Sullivan, EK | 1 |
12 other study(ies) available for nicotine and eticlopride
| Article | Year |
|---|---|
Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression.
Topics: 4-Aminobutyrate Transaminase; Animals; Benzazepines; Conditioning, Classical; Conditioning, Operant; Cues; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; gamma-Aminobutyric Acid; Male; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides; Vigabatrin | 2001 |
Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats.
Topics: Animals; Benzazepines; Brain; Bridged Bicyclo Compounds; Dihydro-beta-Erythroidine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Male; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pyridines; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Dopamine D1; Receptors, Metabotropic Glutamate; Receptors, Nicotinic; Reward; Salicylamides | 2002 |
Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity in rats.
Topics: Animals; Baclofen; Benzazepines; Conditioning, Classical; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; GABA Agonists; GABA-B Receptor Antagonists; Male; Motor Activity; Muscle Relaxants, Central; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D3; Receptors, GABA-B; Salicylamides | 2002 |
Locomotor stimulant effects of nornicotine: role of dopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Drug Synergism; Male; Motor Activity; Nicotine; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Salicylamides; Stimulation, Chemical; Sympathectomy, Chemical; Sympatholytics | 2002 |
The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes.
Topics: Aconitine; Animals; Atropine; Benzazepines; Brain Chemistry; Cerebral Cortex; Dopamine; Dopamine Antagonists; Hippocampus; Male; Microdialysis; Neurotransmitter Agents; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Norepinephrine; Parasympatholytics; Rats; Rats, Sprague-Dawley; Salicylamides; Serotonin | 2005 |
Nicotinic and dopamine D2 receptors mediate nicotine-induced changes in ventral tegmental area neurotensin system.
Topics: Animals; Basal Ganglia; Benzazepines; Corpus Striatum; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mecamylamine; Neuropeptides; Neurotensin; Nicotine; Nicotinic Antagonists; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Tegmentum Mesencephali | 2007 |
Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine.
Topics: Action Potentials; Animals; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Electric Stimulation; In Vitro Techniques; Male; Microdialysis; Neurons; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Piperazines; Quinpirole; Rats; Rats, Long-Evans; Salicylamides; Signal Transduction | 2009 |
Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
Topics: Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Conditioning, Psychological; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Female; Hyperkinesis; Male; Motor Activity; Naphthalenes; Nicotine; Pyrrolidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Sex Characteristics | 2009 |
Effects of dopamine antagonists on drug cue-induced reinstatement of nicotine-seeking behavior in rats.
Topics: Animals; Behavior, Addictive; Benzazepines; Conditioning, Operant; Cues; Dopamine Antagonists; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Nicotine; Rats; Rats, Sprague-Dawley; Salicylamides; Secondary Prevention; Self Administration | 2010 |
Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT(2C) receptor agonist but not by a 5-HT(2A) receptor antagonist.
Topics: Animals; Benzazepines; Conditioning, Classical; Dopamine Antagonists; Ethylamines; Fluorobenzenes; Indoles; Male; Nicotine; Piperidines; Rats, Long-Evans; Reinforcement, Psychology; Salicylamides; Serotonin 5-HT2 Receptor Antagonists | 2014 |
The incentive amplifying effects of nicotine are reduced by selective and non-selective dopamine antagonists in rats.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Conditioning, Classical; Cues; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Flupenthixol; Male; Nicotine; Rats; Reinforcement, Psychology; Salicylamides | 2014 |
Pharmacological challenges examining the underlying mechanism of altered response inhibition and attention due to circadian disruption in adult Long-Evans rats.
Topics: Animals; Attention; Benzazepines; Choline O-Acetyltransferase; Chronobiology Disorders; Circadian Clocks; Circadian Rhythm; Cognition; Disease Models, Animal; Dopamine Antagonists; Female; Gene Expression; Impulsive Behavior; Male; Nicotine; Nicotinic Agonists; Period Circadian Proteins; Rats; Rats, Long-Evans; Reaction Time; Receptors, Dopamine D1; Salicylamides | 2020 |